Yahoo! News: Electricity cap used to treat brain tumors
The University of Cincinnati is one of the trial sites for the TRIDENT clinical trial, testing the effectiveness of electrical field treatment for glioblastoma patients earlier in treatment regimens.
Kyle Wang, MD, a University of Cincinnati Cancer Center member and assistant professor of clinical radiation oncology in the UC College of Medicine, explained that human cells naturally use electricity to line up certain cellular structures, including materials called mitotic spindles, that are used for cell division and growth. To prevent tumor cells from growing, an alternating electric field can be focused at the tumor to disrupt this process.
The treatment is delivered through a group of electrical arrays, a configuration of electrodes that looks like a mesh cap worn on the head, called an Optune device.
A number of local TV stations across the country, as well as Yahoo! News, have featured the research in recent segments.
Watch the Yahoo! News segment, originally aired on NewsChannel 5 Nashville.
Featured photo at top of patient Siyun Huang, right, wearing an Optune device while talking with University of Cincinnati clinical research professional Alexis Brenner, left. Photo/Leigh Vukov/UC Health.
Related Stories
UC student breaks world record in competitive speedcubing
December 19, 2025
UC computer science student Sujan Feist set a new world record in speedcubing at competition this month in Coshocton, Ohio. Feist is the reigning world champion in the 2x2 division.
A partnership to end pancreatic cancer
December 19, 2025
Since 2010, BSI Engineering has raised more than $1.2 million for pancreatic cancer research at the University of Cincinnati Cancer Center in honor of a friend and inspiration to BSI’s founders, Bryan Speicher.
Bazinga! UC physicist cracks ‘Big Bang Theory’ problem
December 19, 2025
A physicist at the University of Cincinnati and his colleagues figured out something two of America’s most famous fictional physicists couldn’t: theoretically how to produce subatomic particles called axions in fusion reactors.